Abeona Therapeutics Inc. (0H7R.L)
USD 5.88
(-2.0%)
USD 5.88
(-2.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -37 Million | -43.48 Million | -65.66 Million | -35.01 Million | -62.82 Million | -39.11 Million |
| Net Income | -54.18 Million | -39.69 Million | -84.93 Million | -84.23 Million | -76.28 Million | -56.67 Million |
| Depreciation & Amortization | 3.19 Million | 4.57 Million | 4.46 Million | 5.6 Million | 8.67 Million | 2.36 Million |
| Deferred income taxes | -11.16 Million | -6.05 Million | -5.91 Million | -21.56 Million | -8.31 Million | -8.89 Million |
| Stock-based compensation | 4.76 Million | 3.05 Million | 8.91 Million | 8.18 Million | 8.23 Million | 8.86 Million |
| Change in working capital | -3.82 Million | -5.89 Million | -18.26 Million | 1.63 Million | -3.55 Million | 6.96 Million |
| Other non-cash items | 13.04 Million | 9.36 Million | 44.17 Million | 55.36 Million | 27.31 Million | 5.26 Million |
| Investing Cash Flow | 208 Thousand | -23.96 Million | 66.06 Million | -83.71 Million | 59.97 Million | -85.08 Million |
| Investments in PPE | -331 Thousand | -130 Thousand | -4.15 Million | -1.33 Million | -6.5 Million | -19.49 Million |
| Acquisitions | 204 Thousand | 1.73 Million | -70.21 Million | 82.37 Million | - | - |
| Investment purchases | -51.63 Million | -78.21 Million | -20.16 Million | -170.47 Million | - | -136.09 Million |
| Sales/Maturities of investments | 51.97 Million | 52.64 Million | 90.37 Million | 88.09 Million | 66.48 Million | 70.5 Million |
| Other Investing Activities | 539 Thousand | -23.83 Million | 70.21 Million | -82.37 Million | 66.28 Million | -75.84 Million |
| Financing Cash Flow | 37.05 Million | 43.17 Million | 24.86 Million | 1.93 Million | 113.9 Million | 5.47 Million |
| Debt repayment | - | - | - | -1.75 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -182 Thousand | -5000.00 | - | - | - | - |
| Common Stock Issuance | 37.2 Million | 43.17 Million | 24.86 Million | 178 Thousand | 113.9 Million | 5.47 Million |
| Other Financing Activities | 37.23 Million | 43.17 Million | 24.86 Million | 178 Thousand | 113.9 Million | 5.47 Million |
| Accounts receivables | -2.04 Million | 2.81 Million | -3 Million | - | 81 Thousand | 26 Thousand |
| Accounts payables | 2.04 Million | -5.49 Million | 825 Thousand | -2.17 Million | -1.7 Million | 7.66 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3.82 Million | -3.21 Million | -16.08 Million | 3.81 Million | -1.92 Million | -731 Thousand |
| Cash at beginning of period | 14.55 Million | 37.92 Million | 12.59 Million | 129.25 Million | 18.75 Million | 137.75 Million |
| Cash at end of period | 14.81 Million | 14.55 Million | 37.92 Million | 12.59 Million | 129.25 Million | 18.75 Million |
| Capital Expenditure | -331 Thousand | -130 Thousand | -4.15 Million | -1.33 Million | -6.5 Million | -19.49 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 256 Thousand | -23.37 Million | 25.33 Million | -116.66 Million | 110.5 Million | -119 Million |
| Free Cash Flow | -37.34 Million | -43.61 Million | -69.81 Million | -36.35 Million | -69.32 Million | -58.6 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 7.4 Million | -31.57 Million | -16.59 Million | -54.18 Million | -11.83 Million | -16.65 Million |
| Depreciation & Amortization | 1.66 Million | 724 Thousand | 721 Thousand | 3.19 Million | 751 Thousand | 838 Thousand |
| Deferred income taxes | - | - | - | -11.16 Million | -5.05 Million | 2.57 Million |
| Stock-based compensation | - | 1.56 Million | 1.51 Million | 4.76 Million | 1.55 Million | 927 Thousand |
| Change in working capital | 2.44 Million | -2.81 Million | 1.01 Million | -1.78 Million | 2.36 Million | -3.15 Million |
| Other non-cash items | -22.99 Million | 22.01 Million | 4.74 Million | 22.01 Million | 2.31 Million | 13.92 Million |
| Investing Cash Flow | -44.13 Million | -7.81 Million | 11.52 Million | 208 Thousand | -18.74 Million | 5.21 Million |
| Investments in PPE | -711 Thousand | -725 Thousand | -37 Thousand | -331 Thousand | -44 Thousand | -32 Thousand |
| Acquisitions | 18 Thousand | - | 17 Thousand | 204 Thousand | 8000.00 | 179 Thousand |
| Investment purchases | -60.54 Million | -29.34 Million | -3.41 Million | -51.63 Million | -34.06 Million | -6.19 Million |
| Sales/Maturities of investments | 17.1 Million | 22.25 Million | 14.96 Million | 51.97 Million | 15.35 Million | 11.25 Million |
| Other Investing Activities | - | -7.09 Million | 11.56 Million | 539 Thousand | -18.69 Million | 5.24 Million |
| Financing Cash Flow | 73.68 Million | 25.44 Million | 7.61 Million | 37.2 Million | 22.97 Million | 6.61 Million |
| Debt repayment | - | -19.03 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -182 Thousand | -182 Thousand | - | - |
| Common Stock Issuance | 73.69 Million | 6.41 Million | 7.6 Million | 37.2 Million | 22.98 Million | 6.62 Million |
| Other Financing Activities | -14 Thousand | -14 Thousand | 13 Thousand | 37.23 Million | -4000.00 | -5000.00 |
| Accounts receivables | 552 Thousand | 252 Thousand | -20 Thousand | -2.04 Million | 3.51 Million | -5.46 Million |
| Accounts payables | 1.56 Million | -1.69 Million | 2.18 Million | 2.04 Million | -1.35 Million | 1.89 Million |
| Inventory | - | - | -1.00 | - | - | - |
| Other working capital | 327 Thousand | -1.37 Million | -1.14 Million | -1.78 Million | 201 Thousand | 413 Thousand |
| Cash at beginning of period | 17.89 Million | 14.81 Million | 5.05 Million | 14.55 Million | 6.56 Million | 5.01 Million |
| Cash at end of period | 34.76 Million | 17.89 Million | 14.81 Million | 14.81 Million | 5.05 Million | 6.56 Million |
| Capital Expenditure | -711 Thousand | -725 Thousand | -37 Thousand | -331 Thousand | -44 Thousand | -32 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 16.86 Million | 3.08 Million | 9.76 Million | 256 Thousand | -1.51 Million | 1.54 Million |
| Free Cash Flow | -13.39 Million | -15.26 Million | -9.42 Million | -37.49 Million | -5.79 Million | -10.31 Million |
SIYSIL
MEDANTA
BIR
TEXRAIL
OGEN
PSHZF